“VSIG4 Regulation of Macrophages and Inflammasome May Alleviate Intestinal Inflammation in Inflammatory Bowel Disease”

https://pubmed.ncbi.nlm.nih.gov/38113649

VSIG4, an anti-inflammatory receptor, may alleviate intestinal inflammation in inflammatory bowel disease by regulating M1/M2 macrophages and inhibiting NLRP3 inflammasome and pyroptosis.